Veralytic Logo

Take a Break from Laboring over Life Insurance Illustrations

Friday, August 30, 2013

Labor Day is a day of rest to commemorate the many days of hard labor, particularly in the early decades of the Industrial Age before Fair Labor Laws and when hard-labor was really hard-labor.  As such, we can think of no better time with Labor Day again approaching to remind readers to take a break from the hard work still typically involved in determining the suitability of a given life insurance product. 

For instance, many practitioners are still comparing illustrations of hypothetical policy values for some limited number of products as the means of determining product suitability.  This practice is time-consuming (i.e., a prominent bank said it took them 4 hours to compare only a fraction of the total products available), incomplete (i.e., because such comparisons inherently include only a fraction of the total products available, the results are unreliable), and for these reasons is deemed “misleading” and prohibited by the chief regulator for the financial services industry. 

Instead, take a break from the hard labor of calculating and comparing some large number of illustrated hypothetical policy values that produce incomplete and “misleading” results, and give Veralytic a try.  Veralytic is simply the fastest, easiest, and most comprehensive and cost-effective way to independently verify to clients and their advisors whether or not the pricing and performance of existing or proposed life insurance is in their best interest. Only Veralytic is accepted for independent client representation, endorsed by the New York Bankers Association (NYBA) and compliant with industry regulations and established case law.

Use the Veralytic Reports to determine the appropriateness of pricing, the reasonableness of performance expectations for invested assets underlying policy cash values, and overall suitability for your (client’s) policies based on the 5 factors of suitability. Click here and get up to 3 Veralytic research reports under our NO-Risk trial subscription.

Comments are closed on this post.